News
Sanofi plans $20 billion US investment by 2030 to expand R&D and manufacturing, aiming to boost medicine production and job ...
A consultancy’s new ranking of drug company R&D shows Eli Lilly has risen to the top of the drug development heap, while ...
More than $13 million in incentives from North Carolina are pledged to a biotech company making a $700 million investment, a ...
After buying thousands of acres in Boone County to home a contentious technology park, the IEDC quietly listed two purchases ...
Roche envisions its Indianapolis site as a “major hub” for the manufacturing of its continuous glucose monitoring systems.
With the active ingredients in drugs like Ozempic and Zepbound no longer in shortage, access to medicine for millions who had ...
Greentech and Roche are planning domestic manufacturing facilities, adding to the list of projects sparked by Trump's push ...
Gov. Mike Braun visited Lebanon Tuesday to help break ground for the $4.5 billion Eli Lilly Medicine Foundry in Lebanon. The foundry is the first research and development site of its kind in the world ...
With more health systems under increasing financial strain and AI adoption on the rise, Iodine is one of the few healthcare AI companies delivering clear, quantifiable results. A recent McKinsey ...
Swiss pharmaceutical giant Roche announced today that it plans to invest 2.04 billion yuan (about $283M) in building a new ...
Trump's order seeks to ease regulations to compel more U.S. drug manufacturing. He also plans to assess tariffs on drug imports.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results